Medovex Reports Two Completed Cases in Germany for DenerveX System

Medovex (NASDAQ:MDVX) reported the initial results from first cases conducted in Germany.

As quoted in the press release:

On July 26, 2017, Dr. Martin Deeg performed two cases in Stuttgart. Dr. Deeg is a member of the Company’s European Medical Advisory Board.

Case summary from Dr. Deeg’s cases:

  • Case One: Female, 40 years old, L4, two joints treated. Patient had injection local only at the facet joint. At the end of the procedure the patient moved herself from the table and walked under her own power out of the procedure room and was discharged shortly after with no pain prescription provided other than over the counter pain relief medicines.
  • Case Two: Male, 42 year old, L5, two joints treated. Patient had an injected local only at the facet joint. At the end of the procedure the patient moved from the table and walked out of the procedure room on their own power and was discharged shortly after, again no pain relief prescriptions provided only over the counter medicines recommended. A picture of Dr. Deeg and patient may be found here on the Company’s Facebook page: https://www.facebook.com/medovex/

Dr. Martin Deeg stated, “Both of the first two DenerveX™ System cases met with what I consider excellent initial success. Both patients experienced initial pain reduction of the Facet Joint during the actual running of the device. Additionally, both patients walked out of the procedure room on their own power and were discharged shortly following the procedure.”

Click here to read the full press release.

Get the Latest Medical Device Investing Stock Information

Get the latest information about companies associated with Medical Device Investing delivered directly to your inbox.

Medical Device

By selecting company or companies above, you are giving consent to receive email from those companies. And remember you can unsubscribe at any time.

Comments

Leave a Reply